MoonLake Share Price
NASDAQ: MLTX | Small Cap | HealthcareMoonLake Stock Performance
MoonLake Share Price Today
As of 22 November 2026, MoonLake Immunotherapeutics Class A's share price is $11.07. The stock opened at $10.72, compared to its previous close of $11.05. During today's trading session, MoonLake Immunotherapeutics Class A's share price traded between $10.72 and $11.29, with an average price of $11.01. Over the past 52 weeks, the stock has recorded a high of $23.25 and a low of $9.47. In terms of performance, MoonLake Immunotherapeutics Class A's share price has declined by 42.24% over the last six months and is down 19.45% on a year-on-year basis.
MoonLake Share Price Chart
MoonLake Quarterly Profit & Loss
All figures in USD
MoonLake Annual Profit & Loss
All figures in USD
MoonLake Balance Sheet
All figures in USD Million
MoonLake Cash Flow
All figures in USD Million
About MoonLake
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.
MoonLake Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $11.88 | $11.04 | -6.20% |
Oct 2026 | $11.69 | $11.77 | +0.34% |
Sep 2026 | $15.05 | $11.72 | -24.55% |
Aug 2026 | $18.37 | $15.54 | -15.75% |
Jul 2026 | $19.75 | $18.45 | -5.26% |
Jun 2026 | $18.91 | $19.47 | +1.54% |
May 2026 | $16.37 | $19.18 | +17.35% |
Apr 2026 | $17.29 | $16.34 | -12.29% |
Mar 2026 | $17.29 | $18.63 | +6.34% |
Feb 2026 | $16.35 | $17.52 | +11.84% |
Jan 2026 | $13.19 | $15.66 | +18.99% |
Dec 2025 | $13.59 | $13.16 | -4.25% |